- Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria2011 | First Faculty of Medicine
- Glatiramer acetate and treatment of multiple sclerosis2015 | Faculty of Medicine in Hradec Králové
- ECTRIMS/ACTRIMS 2017 - News in research and treatment of Multiple Sclerosis2017 | Publication without faculty affiliation
- Radiodiagnostic algorithm of multiple sclerosis2013 | First Faculty of Medicine
- Association of primary idiopathic polymyositis and multiple sclerosis2006 | Publication without faculty affiliation
- Advances in imaging and diagnosing autoimmune and inflammatory diseases2018 | First Faculty of Medicine
- Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes2015 | Third Faculty of Medicine
- Metabolomics of Cerebrospinal Fluid Amino and Fatty Acids in Early Stages of Multiple Sclerosis2023 | Third Faculty of Medicine, Central Library of Charles University
- Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?2024 | First Faculty of Medicine
- Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study2022 | Third Faculty of Medicine
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study2013 | First Faculty of Medicine
- Tau protein, phosphorylated tau protein, and beta-amyloid 42 levels in patients with neurodegenerative diseases complicated by cognitive deficits A non-randomized, concurrent, case-control investigation2009 | Second Faculty of Medicine
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE) : a multicentre, randomised, 24-month, phase 3 trial2019 | First Faculty of Medicine
- Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study A Randomized Clinical Trial2021 | First Faculty of Medicine